Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002619 |
---|---|
Receipt number | R000001598 |
Scientific Title | Phase II study of amrubicin combined with carboplatin for unresectable invasive thymoma or thymic carcinoma |
Date of disclosure of the study information | 2010/03/31 |
Last modified on | 2015/01/30 17:23:48 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/10/12 11:33:18 | ||
2 | Update | 2010/04/12 11:54:08 | Recruitment status |
|
3 | Update | 2010/04/12 11:56:52 | Recruitment status |
|
4 | Update | 2010/10/14 10:34:57 | Name of person sending information Organization Division name Address |
|
5 | Update | 2011/10/12 16:28:12 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
6 | Update | 2012/10/12 10:18:10 | Recruitment status |
|
7 | Update | 2014/10/13 07:25:16 | TEL Last name of contact person Last name of contact person Address Address TEL |
|
8 | Update | 2015/01/30 17:23:48 | Recruitment status |